Table: Ono Pharm -6-MTH group results (IFRS)

ONO PHARMACEUTICAL

01/11/2021 03:00

Nov 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              174.08              150.47           345.00    
                   (+15.7 pct)         (+1.0 pct)       (+11.5 pct) 
  Operating           58.17               52.40           103.00    
                   (+11.0 pct)         (+25.1 pct)      (+4.7 pct)  
  Pretax              59.23               53.67           105.00    
                   (+10.4 pct)         (+24.7 pct)      (+4.1 pct)  
  Net                 46.29               39.85            81.50    
                   (+16.2 pct)         (+21.4 pct)      (+8.1 pct)  
  EPS Basic         92.74 yen           79.84 yen       163.28 yen  
  EPS Diluted       92.73 yen           79.83 yen                   
  Ann Div                               50.00 yen        56.00 yen  
  -Q2 Div           28.00 yen           22.50 yen                   
  -Q4 Div                               27.50 yen        28.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T